In the Schuitemaker study, the authors also found that TSPO levels were comparable between prodromal Alzheimer’s disease patients who progressed to dementia and those who remained stable during the follow-up period (2.7 years, range: 2.3–3.3) [63]. This evidence concerns the gene TSPO and dementia.